REFERENCES
- Boardman, R. H.: Fatal cages of toxic hepatitis implicating chlorpromazine. Brit. M. J. 2: 579 (September 4) 1954.
- Chesney, W. M.: Chlorpromazine and jaundice. Brit. M. J. 2: 591 (September 4) 1954.
- Winkelman, N. W., Jr.: Chlorpromazine in treatment of neuropsychiatry disorders. J.A.M.A. 155: 18 (May 1) 1954.
- Kelley, J. W.: Thorazine-chlorpromazine. Nebraska M.J. 39: 305 (July) 1954.
- Azima, H. and Ogle, W.: Effects of largactil in mental syndromes. Canad. M.A.J. 71: 116 (August) 1954.
- Moyer, J. H. and others: Clinical studies of an anti-emetic agent, chlorpromazine. Am. J. M. Sc. 228: 174 (August) 1954.
- Lemire, R. E. and Mitchell, R. A.: Regurgitation type of jaundice associated with chlorpromazine (Thorazine, S. K. F. 2061A) administration. Paper read at the Midwestern Section Meeting of the American Federation for Clinical Research, October 28, 1954.
- Longaker, E. D.: Personal communication.
- Appel, B. and Jankelson, I. R.: Treatment of arsenical hepatitis with sodium dehydrocholate; experimental and clinical studies in cases of arsphenamine poisoning. Arch. Dermat. & Syph. 32: 422 (September) 1935.
- Pelner, L. and Waldman, S.: Use of adenosine-5-monophosphate in pruritus of obstructive jaundice. Am. J. Digest. Die. 18: 283 (September) 1951.
- Pelner, L. and Waldman, S.: “Replacement” therapy versus “occupation” therapy with adrenal steroids in liver disease. Am. Pract. & Digest. Treat. 3: 976 (December) 1952.
- Werner, S. C., Hanger, F. M. and Kritzler, R. A.: Jaundice during methyl testosterone therapy. Am. J. Med. 8: 325 (March) 1950.
- Brochure on Thorazine. Smith, Kline and French Laboratories, Philadelphia.